FindTrial
Sign In

Personalized Glycemic Control Based on Application Software ( APP ) for Regulating Blood Glucose And Insulin In Critically Ill Patients ——A Prospective and Multicenter Study

Personalized Glycemic Control Based on Application Software ( APP ) for Regulating Blood Glucose And Insulin In Critically Ill Patients ——A Prospective and Multicenter Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066773
Enrollment
Unknown
Registered
2022-12-16
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperglycemia?critially ill patient

Interventions

treatment group:use the application software for regulating insulin and blood glucose to regulating insulin dosage by blood glucose
control group:use paper based protocol to regulate insulin dosage by blood glucose

Sponsors

The first Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: the age of critically ill patients = 18 years old 2 patients with blood glucose = 15mmol/L, who need insulin micropump to control blood glucose 3 the length of ICU stay = 3 days

Exclusion criteria

Exclusion criteria: 1 refusing participating the experiment 2 ketoacidosis, hyperosmotic hyperglycemia syndrome, chronic pancreatitis 3 end-stage of disease

Design outcomes

Primary

MeasureTime frame
blood glucose;HbA1c;—

Countries

China

Contacts

Public ContactYu Huijie

The First Hospital of Jiaxing

yhjtj88@sina.com13957328742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026